A follow-up analysis of CRP levels in the EURIKA population revealed that among patients without T2DM who were not receiving statin treatment, more than one-third had CRP levels of at least 3 mg/l, while almost half had CRP levels of at least 2 mg/l [9]. The gene discussed is CRP; the disease is type 2 diabetes mellitus.